A BRISTOL TENNESSEE BASED DRUG COMPANY HAS EXPERIENCED A REDUCTION IN THIRD QUARTER REVENUE NUMBERS. BUT OFFICIALS WITH KING PHARMACEUTICAL ARE OPTIMISTIC ABOUT LONG TERM GOALS FOR THE COMPANY. TOTAL REVENUES WERE 388 MILLION DOLLARS DURING THE THIRD QUARTER OF THIS YEAR, COMPARED TO 545 MILLION DOLLARS FOR THE SAME PERIOD LAST YEAR.